For Bariatric Surgeons and Their Clinical Staff
Risk Information

Product Specifications

LAP-BAND® System: A Minimally Invasive Approach to Treating Obesity

The LAP-BAND® Adjustable Gastric Banding System is specially designed to limit food consumption in severely obese patients. When placed around the patient's stomach, the saline-filled LAP-BAND® forms a small gastric pouch and stoma. Inflation of the band can be adjusted to control the amount of food a patient can comfortably consume.

Because the LAP-BAND® System is placed laparoscopically, it is intended for use by surgeons with advanced laparoscopic skills. Click here for more information on becoming a certified LAP-BAND® System surgeon.

Laparoscopic placement of the LAP-BAND® System through very small incisions using instruments passed through ports negates the need for a large, open incision. The LAP-BAND® System does not involve cutting or stapling of the stomach. The minimally invasive nature of the LAP-BAND® System means patients are usually back home the day after the surgery and are generally able to resume their regular activities soon after surgery. Shorter hospital stays reduce strain on hospital resources.

Stoma size can be changed post-operatively to help control food intake-and therefore weight loss-by changing the amount of saline in the band through a subcutaneous access port. This eliminates the need for additional surgery for band adjustments. Adding saline to the band reduces stoma size while removing saline from the band increases stoma size.

Safe, Successful Weight Loss

The LAP-BAND® System is an effective and safe strategy to support weight loss in morbidly obese patients. One year after surgery, weight loss with the LAP-BAND® System averages 44%.1 Five-year post-operative weight-loss results with the LAP-BAND® System are comparable to those achieved with gastric bypass surgery. Parikh et al report that the LAP-BAND® System has a very low perioperative severe complication rate (less than 1%).2

Nutrient absorption is not altered in patients with the LAP-BAND® System because the gastrointestinal tract is not drastically altered after placement of the LAP-BAND® System. In contrast, gastric bypass patients may require vitamin supplements for the rest of their lives because their ability to properly absorb nutrients may be compromised following gastric bypass surgery.

RISK INFORMATION

Click here for detailed risk information

References

  1. Ren CJ, Weiner M, Allen JW. Favorable early results of gastric banding for morbid obesity. Surg Endosc. 2004;18:543-546.

    The LAP-BAND AP® System was approved in the United States on the basis of a nonrandomized, single-arm study (N=299). Significant improvement in percent of excess weight loss vs baseline was achieved at 12 months (34.5%), 24 months (37.8%), and 36 months (36.2%).

  2. Parikh MS, Laker S, Weiner M, Hajiseyedjavadi O, Ren CJ. Objective comparison of complications resulting from laparoscopic bariatric procedures. J Am Coll Surg. 2006; 202:252-261.

    Background: Several surgical treatment options for morbid obesity exist. Since no studies have objectively compared complication rates after laparoscopic bariatric operations, a retrospective review of all patients (n=780) undergoing these surgeries at a single institution from September 2000 to July 2003 was performed.

    Complications were categorized according to a standard classification system for surgical procedures. Grading based on the classifications set by Clavien and colleagues.

    Grade I - Events carrying minor risks
    Grade II - Events requiring intervention, eg, drug therapy, TPN, blood transfusions, therapeutics imaging, or reoperation
    Grade III - Events with residual and lasting disability and/or requiring organ resection
    Grade IV - Death as a result of any complication

Featured Item

A Surgical Aid in the Treatment of Morbid Obesity Booklet Spanish

A Surgical Aid in the Treatment of Morbid Obesity Booklet Spanish

This pre surgery brochure should be given to all patients who want to learn more about the risk and benefits of LAP-BAND® System surgery. It includes detailed information about the potential complication of the LAP-BAND® System and is intended to fully inform every patient who decides to proceed with the LAP-BAND® System surgery. Two forms in this book need to be signed by the patient and stored in his or her file, (1) record of book receipt and (2) informed consent

 
Privacy Policy | About Us | Contact Us | Sitemap | Risk Information
© 2010 Allergan, Inc., Irvine CA 92612, U.S.A. ® and TM Mark Owned by Allergan, Inc. All rights reserved. Lindora is a registered trademark owned by Lindora, Inc. COVIDIEN, COVIDIEN with logo and Covidien logo are U.S. and/or internationally registered trademarks of Covidien AG. FITDAY is a registered service mark of Internet Brands, Inc. CareCredit is a registered trademark of CareCredit LLC, General Electric Co, or their subsidiaries. Emmi is a registered trademark owned by Emmi Solutions, LLC. Realize™ is a trademark of Ethicon Endo-Surgery. YouTube is trademark owned by YouTube, LLC.  APC74CS10.
This site is intended for US residents only.